Cargando…
Tumor-derived soluble CD155 inhibits DNAM-1–mediated antitumor activity of natural killer cells
CD155 is a ligand for DNAM-1, TIGIT, and CD96 and is involved in tumor immune responses. Unlike mouse cells, human cells express both membranous CD155 and soluble CD155 (sCD155) encoded by splicing isoforms of CD155. However, the role of sCD155 in tumor immunity remains unclear. Here, we show that,...
Autores principales: | Okumura, Genki, Iguchi-Manaka, Akiko, Murata, Rikito, Yamashita-Kanemaru, Yumi, Shibuya, Akira, Shibuya, Kazuko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144518/ https://www.ncbi.nlm.nih.gov/pubmed/32040157 http://dx.doi.org/10.1084/jem.20191290 |
Ejemplares similares
-
Accelerated tumor growth in mice deficient in DNAM-1 receptor
por: Iguchi-Manaka, Akiko, et al.
Publicado: (2008) -
High expression of soluble CD155 in estrogen receptor-negative breast cancer
por: Iguchi-Manaka, Akiko, et al.
Publicado: (2019) -
Increased CD112 Expression in Methylcholanthrene-Induced Tumors in CD155-Deficient Mice
por: Nagumo, Yoko, et al.
Publicado: (2014) -
Increased Soluble CD155 in the Serum of Cancer Patients
por: Iguchi-Manaka, Akiko, et al.
Publicado: (2016) -
Selective DNAM-1 expression on small peritoneal macrophages contributes to CD4(+) T cell costimulation
por: Takenaka, Eri, et al.
Publicado: (2018)